TY - JOUR
T1 - All-cause and cause-specific mortality from restrictive and obstructive spirometric patterns in Chinese adults with and without dyspnea
T2 - Guangzhou Biobank Cohort Study
AU - Pan, Jing
AU - Adab, Peymane
AU - Jiang, Chao Qiang
AU - Zhang, Wei Sen
AU - Zhu, Xiao-Feng
AU - Jin, Ya Li
AU - Thomas, G Neil
AU - Lam, Tai Hing
PY - 2019/5
Y1 - 2019/5
N2 - Objective To study whether abnormal spirometric patterns were associated with differential mortality in Chinese adults with and without dyspnea. Methods Guangzhou Biobank Cohort Study (GBCS) participants were classified by spirometric patterns and presence of dyspnea into 6 groups: normal spirometry (NS), restriction on spirometry (ROS) and airflow obstruction (AO), each with and without dyspnea. Adjusted hazard ratios (aHRs) were calculated for mortality using Cox models.Results Among 16777 subjects, 1595 (9.5%) had ROS, 1036 (6.2%) had AO and1009 (6.0%) had dyspnea. A total of 1933 deaths (11.9%) occurred during 11-year follow-up. Using NS without dyspnea as reference, NS with dyspnea was significantly associated with increased cardiovascular mortality risk (aHRs 1.61 (95% confidence interval (CI) 1.18-2.19); ROS with and without dyspnea were associated with increased risks of all-cause (aHRs 1.46 (95% CI 1.28-1.66) and 1.81(95% CI 1.33-2.47)) and cardiovascular mortality (aHRs 1.89 (95% CI 1.55-2.31) and 1.85 (95% CI 1.12-3.03)), but not of lung cancer mortality (aHRs 1.33 (95% CI 0.91-1.94) and 1.35 (95% CI 0.49-3.70)); AO with and without dyspnea were associated with increased risks of all-cause (aHRs 1.59 (95% CI 1.36-1.86) and 2.36 (95% CI 1.77-3.15)), cardiovascular (aHRs 1.43 (95% CI 1.08-1.90) and 1.61(95% CI 0.91-2.82)) and lung cancer mortality (aHRs 1.91 (95% CI 1.29-2.84)and 3.01(95% CI 1.46-6.23)). These associations did not vary by sex or smoking status (all P-values for interaction >0.05).Conclusion: Both ROS and AO, with and without dyspnea, were associated with increased all-cause and cardiovascular disease mortality. The increased risk of all-cause was greater and that of cardiovascular mortality was lower for AO than ROS. AO showed significantly increased risk of lung cancer but ROS did not.
AB - Objective To study whether abnormal spirometric patterns were associated with differential mortality in Chinese adults with and without dyspnea. Methods Guangzhou Biobank Cohort Study (GBCS) participants were classified by spirometric patterns and presence of dyspnea into 6 groups: normal spirometry (NS), restriction on spirometry (ROS) and airflow obstruction (AO), each with and without dyspnea. Adjusted hazard ratios (aHRs) were calculated for mortality using Cox models.Results Among 16777 subjects, 1595 (9.5%) had ROS, 1036 (6.2%) had AO and1009 (6.0%) had dyspnea. A total of 1933 deaths (11.9%) occurred during 11-year follow-up. Using NS without dyspnea as reference, NS with dyspnea was significantly associated with increased cardiovascular mortality risk (aHRs 1.61 (95% confidence interval (CI) 1.18-2.19); ROS with and without dyspnea were associated with increased risks of all-cause (aHRs 1.46 (95% CI 1.28-1.66) and 1.81(95% CI 1.33-2.47)) and cardiovascular mortality (aHRs 1.89 (95% CI 1.55-2.31) and 1.85 (95% CI 1.12-3.03)), but not of lung cancer mortality (aHRs 1.33 (95% CI 0.91-1.94) and 1.35 (95% CI 0.49-3.70)); AO with and without dyspnea were associated with increased risks of all-cause (aHRs 1.59 (95% CI 1.36-1.86) and 2.36 (95% CI 1.77-3.15)), cardiovascular (aHRs 1.43 (95% CI 1.08-1.90) and 1.61(95% CI 0.91-2.82)) and lung cancer mortality (aHRs 1.91 (95% CI 1.29-2.84)and 3.01(95% CI 1.46-6.23)). These associations did not vary by sex or smoking status (all P-values for interaction >0.05).Conclusion: Both ROS and AO, with and without dyspnea, were associated with increased all-cause and cardiovascular disease mortality. The increased risk of all-cause was greater and that of cardiovascular mortality was lower for AO than ROS. AO showed significantly increased risk of lung cancer but ROS did not.
KW - Airflow obstruction
KW - Dyspnea
KW - Mortality
KW - Restriction on spirometry
UR - http://www.scopus.com/inward/record.url?scp=85063966300&partnerID=8YFLogxK
U2 - 10.1016/j.rmed.2019.04.002
DO - 10.1016/j.rmed.2019.04.002
M3 - Article
SN - 0954-6111
VL - 151
SP - 66
EP - 80
JO - Respiratory Medicine
JF - Respiratory Medicine
ER -